Viewing SEC Facts Units
Company Name:
Zander Therapeutics, Inc
CIK:
1718644
Start Filing Date:
2018-10-01
End Filing Date:
2018-12-31
ACCN:
0001607062-19-000034
Value:
$ 6,033,001
Value Error:
$ None
Created By:
Date Filed:
2019-01-24
FY:
2019
Fiscal Period:
Q2
Frame:
CY2018Q4
Type:
us-gaap
Form:
10-Q
Units:
shares